Literature DB >> 2753066

Felodipine reduces the absorption of theophylline in man.

T Bratel1, B Billing, R Dahlqvist.   

Abstract

Ten healthy male volunteers (mean age 26 years) received 200 mg theophylline aminopropanol orally 8-hourly for 4 days, followed by 5 mg felodipine 8-hourly for 6 days, and then the combination of oral felodipine and theophylline for a further 4 days. Plasma concentrations of theophylline and felodipine were determined, and theophylline and its metabolites in urine were also measured. Felodipine led to a reduction in the plasma AUC of theophylline of 18.3%. The metabolic and renal clearances of theophylline remained unchanged, but the total recovery of theophylline-derived products was significantly reduced during felodipine treatment. No change in felodipine pharmacokinetics was observed during simultaneous treatment with theophylline. Compared to theophylline treatment alone, the diastolic blood pressure was significantly reduced during felodipine treatment alone and in combination with theophylline. It is concluded that felodipine slightly but significantly lowered the plasma theophylline concentration by interfering with its absorption. The interaction in most instances would probably be of minor clinical consequence.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2753066     DOI: 10.1007/bf00558073

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  Long-term treatment with a new calcium antagonist, felodipine, in chronic obstructive lung disease.

Authors:  T Bratel; G Hedenstierna; O Nyquist; E Ripe
Journal:  Eur J Respir Dis       Date:  1986-05

Review 2.  Clinical pharmacokinetics of felodipine. A summary.

Authors:  B Edgar; P Lundborg; C G Regårdh
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  Felodipine kinetics in healthy men.

Authors:  B Edgar; C G Regårdh; G Johnsson; L Johansson; P Lundborg; I Löfberg; O Rönn
Journal:  Clin Pharmacol Ther       Date:  1985-08       Impact factor: 6.875

4.  Nonlinear theophylline elimination.

Authors:  D D Tang-Liu; R L Williams; S Riegelman
Journal:  Clin Pharmacol Ther       Date:  1982-03       Impact factor: 6.875

5.  Rapid high-performance liquid chromatography assay for salivary and serum caffeine following an oral load. An indicator of liver function.

Authors:  K D Setchell; M B Welsh; M J Klooster; W F Balistreri; C K Lim
Journal:  J Chromatogr       Date:  1987-01-09

6.  Effect of nifedipine and theophylline in asthma.

Authors:  M Garty; E Cohen; A Mazar; D N Ilfeld; S Spitzer; J B Rosenfeld
Journal:  Clin Pharmacol Ther       Date:  1986-08       Impact factor: 6.875

7.  Theophylline metabolism in relation to antipyrine, debrisoquine, and sparteine metabolism.

Authors:  R Dahlqvist; L Bertilsson; D J Birkett; M Eichelbaum; J Säwe; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1984-06       Impact factor: 6.875

8.  Studies on theophylline metabolism: autoinduction and inhibition by antipyrine.

Authors:  C L Denlinger; K K Stryker; L B Slusher; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1987-05       Impact factor: 6.875

9.  Acute diuretic/natriuretic properties of felodipine in man.

Authors:  B Edgar; B Bengtsson; D Elmfeldt; P Lundborg; G Nyberg; S Raner; O Rönn
Journal:  Drugs       Date:  1985       Impact factor: 9.546

10.  Vascular selectivity of felodipine.

Authors:  B Ljung
Journal:  Drugs       Date:  1985       Impact factor: 9.546

View more
  6 in total

Review 1.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

Review 2.  Pharmacokinetic interactions with calcium channel antagonists (Part II).

Authors:  K D Schlanz; S A Myre; M B Bottorff
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

Review 3.  Calcium antagonists. Drug interactions of clinical significance.

Authors:  T Rosenthal; D Ezra
Journal:  Drug Saf       Date:  1995-09       Impact factor: 5.606

Review 4.  Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

Review 5.  Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in older patients.

Authors:  D Faulds; E M Sorkin
Journal:  Drugs Aging       Date:  1992 Sep-Oct       Impact factor: 3.923

Review 6.  Clinical pharmacokinetics of vasodilators. Part II.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.